Evidence map›Paper›PMID 40007036›Full record

ArticleViruses2025

Attenuation of Chikungunya Virus by a Single Amino Acid Substitution in the nsP1 Component of a Non-Structural Polyprotein.

John Chamberlain, Stuart D Dowall, Jack Smith, Geoff Pearson, Victoria Graham, John Raynes, Roger Hewson

Abstract read
In one paragraph

Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

John ChamberlainUK Health Security Agency (UK), Porton Down, Salisbury SP4 0JG, UK.
Stuart D DowallUK Health Security Agency (UK), Porton Down, Salisbury SP4 0JG, UK.
Jack SmithUK Health Security Agency (UK), Porton Down, Salisbury SP4 0JG, UK.
Geoff PearsonUK Health Security Agency (UK), Porton Down, Salisbury SP4 0JG, UK.
Victoria GrahamUK Health Security Agency (UK), Porton Down, Salisbury SP4 0JG, UK.
John RaynesFaculty Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
Roger HewsonUK Health Security Agency (UK), Porton Down, Salisbury SP4 0JG, UK.

Funding

Public Health England N/A
6 · The paper itself

Abstract

Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that, since its re-emergence in 2004, has become recognised as a major public health concern throughout many tropical and sub-tropical regions of the world. Amongst the insights gained from studies on other alphaviruses, several key determinants of virulence have been identified, including one present at the P3 position in the nsP1/nsP2 cleavage domain of the S.A.AR86 Sindbis (SINV) strain. This strain is associated with neurovirulence in adult mice; however, when a threonine-to-isoleucine substitution is engineered at this P3 position, an attenuated phenotype results. A reverse genetics system was developed to evaluate the phenotype that resulted from the substitution of alanine, present at the P3 position in the wild-type CHIKV clone, with valine. The A533V-mutant CHIKV induced milder disease symptoms in the C57BL/6 mouse model than the wild-type virus, in terms of severity of inflammation, length of viraemic period, and histological changes. Furthermore, the induction of type I IFN occurred more rapidly in both CHIKV-infected cell cultures and the mouse model with the mutant CHIKV.

Indexed as

Amino Acid SubstitutionChikungunya FeverChikungunya virusPolyproteinsViral Nonstructural ProteinsAlphavirus InfectionsAnimalsCell LineDisease Models, AnimalFemaleHumansInterferon Type IMiceMice, Inbred C57BLReverse GeneticsVirulenceInterferon Type IPolyproteinsViral Nonstructural ProteinsA533VattenuationChikungunya virusmutationTogaviridae

Identifiers

PMID40007036
PMCPMC11860493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.